about
Autologous haematopoietic stem cell transplantation in juvenile idiopathic arthritisSleep disturbance, daytime sleepiness, and neurocognitive performance in children with juvenile idiopathic arthritis.Factors affecting clinical and therapeutic outcomes of patients with juvenile rheumatoid arthritis.Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General Population.Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study.Emerging therapies offer new methods for treating rheumatoid arthritisClinical pharmacology of celecoxib, a COX-2 selective inhibitor.Abatacept in difficult-to-treat juvenile idiopathic arthritis.Abnormal mandibular growth and the condylar cartilage.Clinical utility of etanercept in the treatment of arthritides in children and adolescents.Biologics in children's autoimmune disorders: efficacy and safety.Children's experiences of living with juvenile idiopathic arthritis: a thematic synthesis of qualitative studies.Tocilizumab: a review of its use in the treatment of juvenile idiopathic arthritis.Pharmacological treatment of chronic non-cancer pain in pediatric patients.Critical appraisal of studies measuring quality of life in juvenile idiopathic arthritis.Management of Juvenile Idiopathic Arthritis: A Clinical Guide.Juvenile idiopathic arthritis: management and therapeutic options.Sleep Fragmentation and Biomarkers in Juvenile Idiopathic Arthritis.
P2860
Q28764481-66CE6746-3DE2-4FFA-B7DC-5EC5A27C455DQ33635459-F658240A-9FF5-4A1C-A34F-4F0DF4E06E85Q35932693-79D12CDE-2EE9-4617-8B12-FB8D9DB187A9Q35999254-4B79A9AC-CBAD-41F1-A14D-78CE4A0F994DQ36552356-5C0F1C1A-E5D0-4886-83E0-369F4ED75068Q36606216-CCE94513-ABEE-4843-A57D-C98320C0EA92Q36904910-6F77B39E-1219-4FFE-ADE6-B87C13AF7A52Q37307846-F3A9DB33-6E62-4EB0-9BB3-E3888F17D991Q37375617-BE8ED58C-DC04-4C93-B702-0AB58719732EQ37676020-0FB119AE-D619-4D9F-BF5B-91FE65C84709Q37765830-D5F010BF-454B-4AA0-9A75-B71A742AB676Q38002779-B05943FE-2755-4CC9-855C-2FD3A5BFD432Q38155126-F7BA126E-E408-4BCE-A503-5AEF84F2BC82Q38258949-F1973629-9977-4523-831F-96607FB0F59FQ38266706-03FC77E1-8999-421C-91D5-13116F4CE8ADQ38916421-3270C394-2ADA-4B80-89DE-D87823358CF7Q39243858-66A5538E-0813-4664-A398-6C2D4EBE49D8Q47923357-5A72D937-0C15-468D-8D24-CCCD8971450B
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Current treatment of juvenile rheumatoid arthritis.
@ast
Current treatment of juvenile rheumatoid arthritis.
@en
Current treatment of juvenile rheumatoid arthritis.
@nl
type
label
Current treatment of juvenile rheumatoid arthritis.
@ast
Current treatment of juvenile rheumatoid arthritis.
@en
Current treatment of juvenile rheumatoid arthritis.
@nl
prefLabel
Current treatment of juvenile rheumatoid arthritis.
@ast
Current treatment of juvenile rheumatoid arthritis.
@en
Current treatment of juvenile rheumatoid arthritis.
@nl
P356
P1433
P1476
Current treatment of juvenile rheumatoid arthritis
@en
P2093
Norman T Ilowite
P304
P356
10.1542/PEDS.109.1.109
P407
P577
2002-01-01T00:00:00Z